Ben is a Clinician Scientist and Group Leader at The Institute of Cancer Research and an Honorary Consultant in Clinical Oncology at The Royal Marsden. He additionally holds a visiting position in Prof Peter Van Loo’s Cancer Genomics group at The MD Anderson Cancer Center in Texas.

Ben’s research is focused on understanding the evolution of resistance to cancer therapies in head and neck cancers, including the use of liquid biopsies. He leads several translational studies and clinical trials at The Institute of Cancer Research and The Royal Marsden.